Results 181 to 190 of about 177,264 (261)

Notes on Three Palustrine Natural Community Types in the Arkansas Ozarks [PDF]

, 1985
Orzell, Steve L., Pell, William F., Tucker, Gary E.   +2 more
core   +2 more sources

A meta-analysis of the safety and efficacy of bosentan therapy combined with prostacyclin analogues or phosphodiesterase type-5 inhibitors for pulmonary arterial hypertension. [PDF]

Exp Ther Med, 2019
Dang ZC, Tang B, Li B, Liu S, Ge RL, Li ZQ, Lu DX.   +6 more
europepmc   +1 more source

Differential Effects of the Phosphodiesterase Type 5 Inhibitors Sildenafil, Vardenafil, and Tadalafil in Rat Aorta

, 2006
Cleber E. Teixeira, Fernanda Priviero, R. Clinton Webb   +2 more
openalex   +1 more source

1-Arylnaphthalene Lignan:  A Novel Scaffold for Type 5 Phosphodiesterase Inhibitor

, 1999
Tatsuzo Ukita, Yoshinori Nakamura, Akira Kubo, Yasuo Yamamoto, Masami Takahashi, Jun Kotera, Tomohiro Ikeo   +6 more
openalex   +1 more source

Comparison of phosphodiesterase type 5 (PDE5) inhibitors

International Journal of Clinical Practice, 2006
openaire   +1 more source

Phosphodiesterase type 5 inhibitors usage and prostate cancer: a match-paired analysis. [PDF]

Transl Androl Urol, 2017
Machen GL, Rajab MH, Pruszynski J, Coffield KS.   +3 more
europepmc   +1 more source

Use of phosphodiesterase type 5 inhibitors and risk of melanoma: a meta-analysis of observational studies. [PDF]

Onco Targets Ther, 2018
Han X, Han Y, Zheng Y, Sun Q, Ma T, Dai L, Zhang J, Xu L.   +7 more
europepmc   +1 more source

Relation of phosphodiesterase type 5 inhibitors and malignant melanoma: a meta-analysis and systematic review. [PDF]

Oncotarget, 2017
Wang J, Shen Y, Wang J, Xue Y, Liao L, Thapa S, Ji K.   +6 more
europepmc   +1 more source

Efficacy and safety of phosphodiesterase type 5 inhibitors for the treatment of distal ureteral calculi of 5 to 10 mm in size: A systematic review and network meta-analysis. [PDF]

Kaohsiung J Med Sci, 2019
Li JK, Qiu S, Jin K, Zheng XN, Tu X, Bi SW, Liao XY, Bao YG, Yang L, Wei Q.   +9 more
europepmc   +1 more source

In silico prediction of novel phosphodiesterase type-5 inhibitors derived from Sildenafil, Vardenafil and Tadalafil

, 2008
João Eustáquio Antunes, Matheus P. Freitas, Elaine F. F. da Cunha, Teodorico C. Ramalho, Roberto Rittner   +4 more
openalex   +1 more source